Ligand Pharmaceuticals
LGND
LGND
221 hedge funds and large institutions have $1.21B invested in Ligand Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $1.17B → $1.21B (+$38.4M)
0.55% less ownership
Funds ownership: 93.71% → 93.16% (-0.55%)
13% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 72
Holders
221
Holding in Top 10
2
Calls
$7.41M
Puts
$2.29M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$14.4M | |
| 3 | +$6.08M | |
| 4 |
DIA
Dana Investment Advisors
Waukesha,
Wisconsin
|
+$5.54M |
| 5 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$4.58M |
Top Sellers
| 1 | -$24.5M | |
| 2 | -$23.3M | |
| 3 | -$10.7M | |
| 4 |
BlackRock
New York
|
-$6.87M |
| 5 |
Man Group
London,
United Kingdom
|
-$5.54M |